---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-038742"
form_type: "8-K"
ticker: "BPTH"
cik: "0001133818"
company_name: "BIO-PATH HOLDINGS, INC."
filed_at: "2024-03-26T23:59:59+00:00"
generated_at: "2026-06-04T07:36:30.433396+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Bio-Path raises ~$299k in registered direct offering; issues warrants

## Summary
- Gross proceeds of $299,250 from 75,000 shares at $3.99/share; net ~$0.2M after fees.
- Common warrants to purchase up to 75,000 shares at $3.865, 5-year term, immediate exercise.
- Placement agent H.C. Wainwright gets 7.5% fee plus warrants for 5,625 shares at $4.9875.
- Proceeds for working capital; closing expected March 27, 2024.

## SEC filing metadata
- accession: 0001104659-24-038742
- form_type: 8-K
- ticker: BPTH
- cik: 0001133818
- company_name: BIO-PATH HOLDINGS, INC.
- filed_at: 2024-03-26T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1133818/000110465924038742/0001104659-24-038742-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1133818/000110465924038742/tm249787d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-038742
- JSON: https://secwatch.observer/filing/0001104659-24-038742.json
- Plain text: https://secwatch.observer/filing/0001104659-24-038742.txt

## Key facts
- Material Agreements
  BIO-PATH HOLDINGS, INC. entered into Purchase Agreement with an institutional investor valued at gross proceeds of $299,250 (effective 2024-03-25).
  - Action: entry
  - Agreement: equity purchase
  - Counterparty: an institutional investor
  - Value: gross proceeds of $299,250
  - Effective: 2024-03-25
  source text: On March 25, 2024, Bio-Path Holdings, Inc. (the “Company”) entered into a securities purchase agreement (the “Purchase Agreement”) with an institutional investor, pursuant to which the Company agreed to sell, in a registered direct offering (the “Registered Direct Offering”), an aggregate of 75,000 shares (the “Shares”) of its common stock, par value $0.001 per share (“Common Stock”), for a purchase price per Share of $3.99 and gross proceeds of $299,250.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1133818/000110465924038742/0001104659-24-038742-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.